Proteins that shuttle in cells may drive aging
Cells are filled with proteins that continuously shuttle between the nucleus and the surrounding cytoplasm. With age, that traffic becomes dysregulated. A new hypothesis argues this disrupted transport is a central cause of aging, not merely a side effect.
Aging is often explained by proteins that misfold or fail to be cleared. But a recent theoretical article proposes a different diagnosis: proteins end up in the wrong place not only because of structural defects, but because the transport machinery between the nucleus and the rest of the cell deteriorates. These transport proteins are called karyopherins (importins, exportins, and biportins).
Karyopherins move proteins through the nuclear pore complex (NPC), the gated channels in the nuclear membrane. The researchers argue that karyopherins are not merely passive couriers. They also regulate protein solubility and prevent proteins from clumping into harmful aggregates, known as pathological condensates, within the cell.
Transport as a central regulator, not a background process
When karyopherin function declines with age, proteins end up in the wrong cellular compartment. Signaling pathways become uncoupled from their proper locations. This has consequences for gene regulation, for how cells respond to stress, and for the emergence of age-related diseases. The authors connect this to familiar aging processes: loss of proteostasis (the ability of cells to keep their protein balance in order), shifts in gene activity, and the formation of harmful protein aggregates seen in diseases like Alzheimer’s and Parkinson’s.
Promising targets for intervention
This is a theoretical review article, published in Aging Cell. No new experiments are presented. The authors themselves acknowledge that the central role of karyopherins remains largely to be proven through targeted interventions, in the same way that senolytic drugs clarified the role of cellular senescence in aging. The hypothesis has practical implications though: karyopherins are in principle targetable with small molecules. If future research confirms that their decline drives aging, that opens a path toward new therapies. For now, this is a conceptual framework, not a proven mechanism. The shift in focus from protein quality to protein location is a meaningful addition to existing aging theories.
Want to research this yourself? Search for: karyopherin nucleocytoplasmic transport aging, nuclear pore complex dysfunction aging, proteostasis spatial regulation